DPY19L2: A Potential Drug Target Or Biomarker (G554236)

Target Name: DPY19L2P1

NCBI ID: G554236

DPY19L2P1

Other Name(s): DPY19L2 pseudogene 1

DPY19L2: A Potential Drug Target Or Biomarker

DPY19L2P1, also known as DPY19L2 pseudogene 1, is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

The DPY19L2 gene is located on chromosome 19q and encodes a protein known as DPY19L2, which is involved in the intracellular signaling pathway known as the TGF-β pathway. This pathway is a key regulator of cell growth, differentiation, and survival, and is implicated in numerous diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

DPY19L2 has been shown to play a role in several diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. For example, studies have shown that high levels of DPY19L2 are associated with an increased risk of cancer, and that inhibiting its activity may be a promising strategy for cancer treatment.

In addition to its potential as a drug target,DPY19L2 has also been identified as a potential biomarker for several diseases. For example, studies have shown thatDPY19L2 is expressed in the brains of individuals with neurodegenerative disorders, and that its levels are associated with the severity of these disorders. This suggests thatDPY19L2 may be a useful biomarker for tracking the progression of neurodegenerative disorders.

Another promising application ofDPY19L2 is its potential as a therapeutic target for autoimmune diseases.DPY19L2 has been shown to be involved in the development and maintenance of autoimmune diseases, and that inhibiting its activity may be a promising strategy for treating these diseases.

In conclusion,DPY19L2P1 is a gene that has the potential to be a drug target or biomarker for a variety of diseases. Further research is needed to fully understand its role in these diseases and to develop effective treatments.

Protein Name: DPY19L2 Pseudogene 1

Functions: Probable C-mannosyltransferase that mediates C-mannosylation of tryptophan residues on target proteins

The "DPY19L2P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DPY19L2P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets